Home/BiomX/Jonathan Solomon
JS

Jonathan Solomon

Chief Executive Officer

BiomX

BiomX Pipeline

DrugIndicationPhase
BX001Mild-to-Moderate Acne VulgarisPhase 2
BX002Crohn's Disease (AIEC+)Phase 1b/2a
BX003Colorectal Cancer (Adjuvant)Preclinical